A team of 24 researchers from the U.S., Europe, Taiwan and Japan and led by University of Illinois scientists has engineered a new anti-cancer agent that is about 200 times more active in killing tumor cells than similar drugs used in recent clinical trials.
Full article >>
Wednesday, March 25, 2009
New drug agent knocks out multiple enzymes in cancer pathway
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment